Marquet Magda 4
4 · Immix Biopharma, Inc. · Filed Jun 21, 2024
Insider Transaction Report
Form 4
Marquet Magda
Director
Transactions
- Award
Stock Option (Right to Buy)
2024-06-11+33,000→ 33,000 totalExercise: $2.04Exp: 2034-06-11→ Common Stock (33,000 underlying)
Holdings
- 20,000(indirect: By LLC)
Common Stock
- 46,092
Common Stock
Footnotes (1)
- [F1]The Stock Option will vest in twelve (12) equal monthly installments following the date of grant, subject to the Reporting Person's continued service with the Issuer.